TY - JOUR
T1 - Xenon‐augmented pediatric anesthesia
T2 - A small step closer?
AU - Gill, Hannah
PY - 2017/11/6
Y1 - 2017/11/6
N2 - There are current concerns regarding the potential for anesthetic-induced neurotoxicity in the developing brain, and in the United States, the Food and Drug Administration has issued warnings regarding the use of all the commonly used general anesthetic drugs in early life. There is preclinical evidence that xenon reduces anesthetic-induced neurotoxicity.1 This means that the report, in this edition of Pediatric Anesthesia, of a randomized, controlled, clinical trial using xenon as an adjunct to sevoflurane anesthesia in young children is an important proof of concept.
AB - There are current concerns regarding the potential for anesthetic-induced neurotoxicity in the developing brain, and in the United States, the Food and Drug Administration has issued warnings regarding the use of all the commonly used general anesthetic drugs in early life. There is preclinical evidence that xenon reduces anesthetic-induced neurotoxicity.1 This means that the report, in this edition of Pediatric Anesthesia, of a randomized, controlled, clinical trial using xenon as an adjunct to sevoflurane anesthesia in young children is an important proof of concept.
U2 - 10.1111/pan.13265
DO - 10.1111/pan.13265
M3 - Editorial (Academic Journal)
VL - 27
SP - 1174
EP - 1175
JO - Pediatric Anesthesia
JF - Pediatric Anesthesia
IS - 12
ER -